✦ LIBER ✦

Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction

✍ Scribed by Jay H. Traverse; David H. McKenna; Karen Harvey; Beth C. Jorgenso; Rachel E. Olson; Nancy Bostrom; Diane Kadidlo; John R. Lesser; Vikrant Jagadeesan; Ross Garberich; Timothy D. Henry

Book ID: 116192191
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 268 KB
Volume: 160
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2010.06.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

INTRACORONARY STEM CELL THERAPY IN PATIE

INTRACORONARY STEM CELL THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION – 36 MONTHS RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL WITH SERIAL MRI FOLLOW-UPS

✍ Jochen Woehrle; Fabian von Scheidt; Sinisa Markovic; Peter Schauwecker; Klaus Sc 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Rationale and design for TIME: A phase I

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

✍ Jay H. Traverse; Timothy D. Henry; Douglas E. Vaughn; Stephen G. Ellis; Carl J. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 158 KB

In-stent neo-intimal hyperplasia after s

In-stent neo-intimal hyperplasia after stem cell mobilization by granulocyte-colony stimulating factor: Preliminary intracoronary ultrasound results from a double-blind randomized placebo-controlled study of patients treated with percutaneous coronary intervention for ST-elevation myocardial infarction (STEMMI Trial)

✍ Erik Jørgensen; Rasmus S. Ripa; Steffen Helqvist; Yongzhong Wang; Hans Erik John 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Rationale and design of the Transendocar

Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy

✍ Barry Trachtenberg; Darcy L. Velazquez; Adam R. Williams; Ian McNiece; Joel Fish 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 322 KB